# Neumora Therapeutics, Inc.: Form SCHEDULE 13D/A, filed Apr 1, 2026

- Company: [Neumora Therapeutics, Inc.](/companies/nmra.md) (CIK 1885522)
- Form: SCHEDULE 13D/A
- Filed: 2026-04-01
- Accepted by EDGAR: Apr 1, 2026, 16:10 ET
- Period: not reported
- Accession: 0001012975-26-000294
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1885522/000101297526000294/xslSCHEDULE_13D_X02/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1885522/000101297526000294/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1885522/000101297526000294/xslSCHEDULE_13D_X02/primary_doc.xml

Filed Apr 1, 2026.
Source: SEC EDGAR, the filing index for accession 0001012975-26-000294. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.